Which Has Superior Acid-Suppressive Effect, 10 Mg Omeprazole Once Daily or 20 Mg Famotidine Twice Daily? Effects of Single or Repeated Administration in Japanese Helicobacter Pylori-Negative CYP2C19 Extensive Metabolizers

By Shimatani Tomohiko   Inoue Masaki   Kuroiwa Tomoko   Moriwaki Mutsuko   Xu Jing   Ikawa Kazuro   Morikawa Norifumi   Tazuma Susumu  

Digestive Diseases and Sciences, Vol. 52, Iss. 2, 2007-02 ,pp. : 390-395

Springer Publishing Company

Access to resources Recommend Favorite

Acid-Suppressive Effect of Rabeprazole 5 mg and 10 mg Once Daily by 24-Hour Esophageal pH Monitoring in Patients with Non-erosive Reflux Disease in Japan: A Multicenter, Randomized, Parallel-Group, Double-Blind Pharmacodynamic Study

By Ashida Kiyoshi  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2333-2342

Springer Publishing Company

Access to resources Recommend Favorite

Esomeprazole 40 mg Provides Improved Intragastric Acid Control as Compared with Lansoprazole 30 mg and Rabeprazole 20 mg in Healthy Volunteers

By  

Digestion, Vol. 68, Iss. 4, 2004-02 ,pp. : 184-188

Karger

Access to resources Recommend Favorite

Sleep Disturbances and Refractory Gastroesophageal Reflux Disease Symptoms in Patients Receiving Once-Daily Proton Pump Inhibitors and Efficacy of Twice-Daily Rabeprazole Treatment

By  

Digestion, Vol. 88, Iss. 3, 2013-09 ,pp. : 145-152

Karger

Access to resources Recommend Favorite

The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in Japan

By Kinoshita Yoshikazu   Kobayashi Takeaki   Kato Mototsugu   Asahina Kan   Haruma Ken   Shimatani Tomohiko   Inoue Shuji   Kabemura Teppei   Kurosawa Susumu   Kuwayama Hajime   Ashida Kiyoshi   Hirayama Michiaki   Kiyama Satoshi   Yamamoto Munemitsu   Suzuki Junichi   Suzuki Hiroyuki   Matsumoto Katsuhiko   Aoshima Masaru  

Journal of Gastroenterology, Vol. 41, Iss. 6, 2006-06 ,pp. : 554-561

Springer Publishing Company

Access to resources Recommend Favorite